157 related articles for article (PubMed ID: 35726125)
1. LncRNA MALAT1 Regulates USP22 Expression Through EZH2-Mediated H3K27me3 Modification to Accentuate Sepsis-Induced Myocardial Dysfunction.
Xu H; Ye W; Shi B
Cardiovasc Toxicol; 2022 Sep; 22(9):813-830. PubMed ID: 35726125
[TBL] [Abstract][Full Text] [Related]
2. Ulinastatin protects against lipopolysaccharide-induced cardiac microvascular endothelial cell dysfunction via downregulation of lncRNA MALAT1 and EZH2 in sepsis.
Yu Z; Rayile A; Zhang X; Li Y; Zhao Q
Int J Mol Med; 2017 May; 39(5):1269-1276. PubMed ID: 28405676
[TBL] [Abstract][Full Text] [Related]
3. MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy.
Wang C; Liu G; Yang H; Guo S; Wang H; Dong Z; Li X; Bai Y; Cheng Y
Sci Total Environ; 2021 Apr; 766():142191. PubMed ID: 33097254
[TBL] [Abstract][Full Text] [Related]
4. LncRNA JPX targets SERCA2a to mitigate myocardial ischemia/reperfusion injury by binding to EZH2.
Bao J; Zhang C; Chen J; Xuan H; Wang C; Wang S; Yin J; Liu Y; Li D; Xu T
Exp Cell Res; 2023 Jun; 427(1):113572. PubMed ID: 36990422
[TBL] [Abstract][Full Text] [Related]
5. Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial-mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract.
Lu L; Luo F; Liu Y; Liu X; Shi L; Lu X; Liu Q
Toxicol Appl Pharmacol; 2015 Dec; 289(2):276-85. PubMed ID: 26415832
[TBL] [Abstract][Full Text] [Related]
6. Elevated lncRNA-UCA1 upregulates EZH2 to promote inflammatory response in sepsis-induced pneumonia via inhibiting HOXA1.
Zhang X; Tang X; Pan L; Li Y; Li J; Li C
Carcinogenesis; 2022 May; 43(4):371-381. PubMed ID: 35018436
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA MALAT1 enhances the apoptosis of cardiomyocytes through autophagy inhibition by regulating TSC2-mTOR signaling.
Hu H; Wu J; Yu X; Zhou J; Yu H; Ma L
Biol Res; 2019 Nov; 52(1):58. PubMed ID: 31783925
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic condition induced H3K27me3 modification of the LncRNA Tmem235 promoter thus supporting apoptosis of BMSCs.
Zhang F; Luo H; Peng W; Wang L; Wang T; Xie Z; Zhang J; Dong W; Zheng X; Liu G; Zhu X; Kang Q; Tian X
Apoptosis; 2022 Oct; 27(9-10):762-777. PubMed ID: 35779185
[TBL] [Abstract][Full Text] [Related]
9. Silencing of Long Noncoding RNA MIAT Contributes to Relieving Sepsis-Induced Myocardial Depression via the NF-κB Axis.
Chen H; Meng S; Liu C; Liu F; Ding F; Hu Y; Cheng Z
J Surg Res; 2022 Oct; 278():282-292. PubMed ID: 35636204
[TBL] [Abstract][Full Text] [Related]
10. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p.
Qin WX; Shi Y; Zhu D; Li YP; Chen YH; Cui J; Cui GY; Pan JX; Ren ZY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3204-3214. PubMed ID: 32271438
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.
Wang X; Sehgal L; Jain N; Khashab T; Mathur R; Samaniego F
J Transl Med; 2016 Dec; 14(1):346. PubMed ID: 27998273
[TBL] [Abstract][Full Text] [Related]
12. lncRNA MALAT1 Accelerates Skeletal Muscle Cell Apoptosis and Inflammatory Response in Sepsis by Decreasing BRCA1 Expression by Recruiting EZH2.
Yong H; Wu G; Chen J; Liu X; Bai Y; Tang N; Liu L; Wei J
Mol Ther Nucleic Acids; 2020 Mar; 19():97-108. PubMed ID: 31830649
[TBL] [Abstract][Full Text] [Related]
13. Silencing of long non-coding RNA MALAT1 suppresses inflammation in septic mice: role of microRNA-23a in the down-regulation of MCEMP1 expression.
Xie W; Chen L; Chen L; Kou Q
Inflamm Res; 2020 Feb; 69(2):179-190. PubMed ID: 31893303
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis.
Chen S; Wang G; Tao K; Cai K; Wu K; Ye L; Bai J; Yin Y; Wang J; Shuai X; Gao J; Pu J; Li H
Cancer Sci; 2020 May; 111(5):1582-1595. PubMed ID: 32129914
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
Chen M; Xia Z; Chen C; Hu W; Yuan Y
Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer.
Wang D; Ding L; Wang L; Zhao Y; Sun Z; Karnes RJ; Zhang J; Huang H
Oncotarget; 2015 Dec; 6(38):41045-55. PubMed ID: 26516927
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MALAT1 promotes colorectal cancer development by sponging miR-363-3p to regulate EZH2 expression.
Xie JJ; Li WH; Li X; Ye W; Shao CF
J Biol Regul Homeost Agents; 2019; 33(2):331-343. PubMed ID: 30972996
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MALAT1 protects cardiomyocytes from isoproterenol-induced apoptosis through sponging miR-558 to enhance ULK1-mediated protective autophagy.
Guo X; Wu X; Han Y; Tian E; Cheng J
J Cell Physiol; 2019 Jul; 234(7):10842-10854. PubMed ID: 30536615
[TBL] [Abstract][Full Text] [Related]
19. Effects of lncRNA MALAT1-mediated β-catenin signaling pathway on myocardial cell apoptosis in rats with myocardial ischemia/reperfusion injury.
Xu XZ; Luo B; Xiao Y; Zheng WQ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9557-9565. PubMed ID: 31773707
[TBL] [Abstract][Full Text] [Related]
20. MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2.
Li P; Zhang X; Wang H; Wang L; Liu T; Du L; Yang Y; Wang C
Mol Cancer Ther; 2017 Apr; 16(4):739-751. PubMed ID: 28069878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
